{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:19:54Z","timestamp":1788941994843,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jcf.2021.07.014","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T16:01:17Z","timestamp":1628438477000},"page":"202-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The impact of liver disease on mortality in cystic fibrosis\u2013A systematic review"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-8197","authenticated-orcid":false,"given":"Ao","family":"Sasame","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4319-8048","authenticated-orcid":false,"given":"Diarmuid","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2701-830X","authenticated-orcid":false,"given":"Marion","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2021.07.014_bib0001","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its realtion to celiac disease","volume":"56","author":"Andersen","year":"1938","journal-title":"Am J Dis Child"},{"issue":"8","key":"10.1016\/j.jcf.2021.07.014_bib0002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.2004.062786","article-title":"Patterns of GI disease in adulthood associated with mutations in the CFTR gene","volume":"56","author":"Wilschanski","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jcf.2021.07.014_bib0003","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/j.1536-4801.1982.tb08374.x","article-title":"Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts","volume":"1","author":"Roy","year":"1982","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.jcf.2021.07.014_bib0004","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","article-title":"Cirrhosis and other liver disease in cystic fibrosis","volume":"12","author":"Flass","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2021.07.014_bib0005","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0006","first-page":"32","article-title":"Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?","volume":"25","author":"Potter","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.jcf.2021.07.014_bib0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.81.2.129","article-title":"The evolution of liver disease in cystic fibrosis","volume":"81","author":"Ling","year":"1999","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jcf.2021.07.014_bib0008","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jcf.2021.07.014_bib0009","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1067\/S0022-3476(03)00329-9","article-title":"Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors","volume":"143","author":"Lenaerts","year":"2003","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2016.08.002","article-title":"Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen","volume":"16","author":"Woodruff","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0011","first-page":"69","article-title":"Liver disease in cystic fibrosis","volume":"15","author":"Leeuwen","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2021.07.014_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2019.12.033","article-title":"Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease: interim results of a prospective observational case-controlled study","volume":"219","author":"Siegel","year":"2020","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.jcf.2021.07.014_bib0013","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/lt.20465","article-title":"Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation","volume":"11","author":"Gooding","year":"2005","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.jcf.2021.07.014_bib0014","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcf.2014.05.013","article-title":"Outcome in patients with cystic fibrosis liver disease","volume":"14","author":"Rowland","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2021.07.014_bib0016","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jhep.2011.03.028","article-title":"Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation","volume":"55","author":"Chryssostalis","year":"2011","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jcf.2021.07.014_bib0017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcf.2018.11.009","article-title":"Cirrhosis associated with decreased survival and a 10-year lower median age at death of cystic fibrosis patients in the Netherlands","volume":"18","author":"Pals","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"8237","key":"10.1016\/j.jcf.2021.07.014_bib0018","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0140-6736(81)90422-0","article-title":"Hepatic complications of cystic fibrosis","volume":"2","author":"Psacharopoulos","year":"1981","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jcf.2021.07.014_bib0019","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/adc.69.3.407","article-title":"Liver cirrhosis in cystic fibrosis","volume":"69","author":"Stringer","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2021.07.014_bib0020","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2021.07.014_bib0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.12688\/hrbopenres.13065.1","article-title":"The impact of liver disease on mortality in cystic fibrosis\u2014a systematic review protocol","volume":"3","author":"Sasame","year":"2020","journal-title":"HRB Open Res"},{"issue":"7","key":"10.1016\/j.jcf.2021.07.014_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0023","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0024","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ajg.2010.316","article-title":"Outcome in cystic fibrosis liver disease","volume":"106","author":"Rowland","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-6143.2007.02028.x","article-title":"Cystic fibrosis liver disease: to transplant or not to transplant?","volume":"8","author":"Nash","year":"2008","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.jcf.2021.07.014_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(76)80247-8","article-title":"Symptomatic hepatic disease in cystic fibrosis, incidence,course and outcome of portal systemic shunting","volume":"70","author":"Stern","year":"1976","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0027","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80166-4","article-title":"Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension","volume":"31","author":"Debray","year":"1999","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hep.24014","article-title":"Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy","volume":"53","author":"Lewindon","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jcf.2021.07.014_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212779","article-title":"The emerging burden of liver disease in cystic fibrosis patients: a UK nationwide study","volume":"14","author":"Toledano","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jcf.2021.07.014_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.jcf.2021.07.014_bib0031","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1478-3231.2007.01570.x","article-title":"The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid","volume":"27","author":"Desmond","year":"2007","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jcf.2021.07.014_bib0032","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/adc.66.6.698","article-title":"Prevalence of liver disease in cystic fibrosis","volume":"66","author":"Scott-Jupp","year":"1991","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jcf.2021.07.014_bib0033","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/adc.68.5.653","article-title":"Liver cirrhosis in cystic fibrosis\u2013therapeutic implications and long term follow up","volume":"68","author":"Feigelson","year":"1993","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.jcf.2021.07.014_bib0034","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jcf.2019.09.016","article-title":"Occurrence, outcomes and predictors of portal hypertension in cystic fibrosis: a longitudinal prospective birth cohort study","volume":"19","author":"Cipolli","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2021.07.014_bib0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MPG.0000000000001728","article-title":"Variceal hemorrhage and adverse liver outcomes in patients with cystic fibrosis cirrhosis","volume":"66","author":"Ye","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.jcf.2021.07.014_bib0036","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jcf.2007.10.004","article-title":"A single centre experience of liver disease in adults with cystic fibrosis 1995-2006","volume":"7","author":"Nash","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2021.07.014_bib0037","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/thx.52.4.313","article-title":"A prognostic model for the prediction of survival in cystic fibrosis","volume":"52","author":"Hayllar","year":"1997","journal-title":"Thorax"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932101328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932101328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:44:42Z","timestamp":1761601482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932101328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S156919932101328X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2021.07.014","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of liver disease on mortality in cystic fibrosis\u2013A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2021.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}